Thijs Van de Vyver

Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner

Thijs Van de Vyver, Bram Bogaert, Lynn De Backer et al. · ACS Nano · 2020 · 76 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells

Freya Joris, Lynn De Backer, Thijs Van de Vyver et al. · Journal of Controlled Release · 2017 · 58 citations · Full text

Pharmacy, Molecular Biology, Pharmaceutics +14

Glycation in human fingernail clippings using ATR-FTIR spectrometry, a new marker for the diagnosis and monitoring of diabetes mellitus

Renaat Coopman, Thijs Van de Vyver, Antoine Sadiki Kishabongo et al. · Clinical Biochemistry · 2016 · 55 citations

Life Sciences, Biochemistry, Endocrinology +16

Surfactant Protein B Promotes Cytosolic SiRNA Delivery by Adopting a Virus-like Mechanism of Action

Roberta Guagliardo, Lore Herman, Jelle Penders et al. · ACS Nano · 2021 · 40 citations · Full text

Pharmacy, Molecular Biology, Pharmaceutics +17

Hydrogel‐Induced Cell Membrane Disruptions Enable Direct Cytosolic Delivery of Membrane‐Impermeable Cargo

Jelter Van Hoeck, Thijs Van de Vyver, Aranit Harizaj et al. · Advanced Materials · 2021 · 20 citations · Full text

Pharmacy, Bioengineering, Biotechnology +16